Stem Cell Researchers Target Knee Injuries
A new treatment uses a patient's stem cells to fix tears in the knee's meniscal cartilage, the Daily Telegraph reports. Scientists are ready to try the procedure out on people.
The newspaper explained how it works: "They placed the cells inside the tear, held in place by a spongy scaffold made from collagen, and found the stem cells brought the two pieces of torn cartilage together."
The procedure uses stem cells taken from bone marrow, and is described as a "living bandage."
Meniscal cartilage tears are a common injury among athletes, and are not easy to repair. Many people choose to risk future osteoarthritis problems by having the cartilage removed altogether.
The "living bandage" is the latest use scientists have found for adult stem cells in humans, and the potential for many more applications are being explored.
Injuries that used to end horses’ careers are being repaired with their own stem cells, reports Wired magazine. National Institutes of Health researchers are growing human spinal disks, cartilage and muscle in the labs, though the tissues aren’t ready to be used yet.
“Stem cells are very promising, but what they do for horses may not work so well for humans because humans are the hardest animal to rebuild,” said Rocky Tuan, a researcher at NIH, in an interview with Wired.
Last year, another research team said it was able to reprogram human skin cells to act like embryonic stem cells, or cells that can turn into any type of human tissue.
In the past decade, science has learned quite a bit about what adult stem cells can and can’t do. Adult stem cells don’t carry any federal limits or the baggage embryonic stem cells do.
But not all adult stem cell research has been so promising. Scientists haven’t been able to replicate some of the most exciting adult stem cell studies, according to Scientific American. Another NIH researcher, Eva Mezey, told Scientific American last year that embryonic stem cells are still more versatile than adult stem cells.
“The end result of the policy is that, anything goes if you have your own money. This slowed down all of the richest universities, but did not stop them, because research was still permitted on the ‘presidentially approved’ lines,” Robey wrote.
Though the development of another series of stem cells that look like embryonic stem cells does not make human embryo stem cell research unnecessary, they do have their benefits.
“These cells do present a true middle ground between the scientific proponents and religious opponents to [human embryonic stem cell] research,” he wrote on the blog Clashing Culture.
But Yuval Levin, a fellow at the Ethics and Public Policy Center in Washington, D.C., believes advances in other types of stem cells may be the answer to the embryonic stem cell ethics debate.
“I think that, in time, this probably will be the final chapter of this particular debate about embryonic stem cells, but I don’t think we’re at the end of it quite yet,” Levin said in a July interview with The Pew Forum on Religion & Public Life.